Ask your doctor (you dumb shit.. not you Black Swan) tag line to every drug commercial
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Family learns BRCA test was wrong — after 7 women had major surgery
By Sara Dorn
December 21, 2019 | 9:19pm | Updated
Enlarge Image
Women outside of the Supreme Court as arguments were made in a case seeking to determine whether human genes can be patented by Myriad Genetics.Getty Images
MORE ON: BREAST CANCER
Losing even a modest amount of weight could reduce breast cancer risk: study
10-day breast cancer therapy as effective as 6-week alternative: study
Why am I 'not qualified' for a cancer study I was already approved for?
Permanent hair dye linked to increased risk of breast cancer: study
A series of lab tests that detected a potentially dangerous gene in seven women from one family were wrong, the family learned earlier this year — after they underwent major surgeries to reduce their chances of cancer.
“I treated my test results like the Bible,” Katy Mathes, a 37-year-old Colorado elementary school teacher told The Wall Street Journal. “There was no questioning the report.”
The results showed she had up to an 84% risk of breast cancer by age 70; the risk for the general population is about 7.3% at that age.
Mathes, her younger sister, their mother and four relatives had surgery to remove their ovaries and fallopian tubes. Mathes and her sister also had double mastectomies.
But this year, they learned the test results they received in the 1990s from Myriad Genetics weren’t as bad as they originally thought, with the company reclassifying the genetic variant from “pathogenic” to having “unknown significance.”
“My brain just shut off,” Mathes said about the moment she learned the test was wrong.
The Salt Lake City-based company, which pioneered BRCA-gene testing in the early 1990s, said it realized the error as more results came back as “of unknown significance.”
“We know these are very difficult situations,” said Susan Manley, senior vice president of medical services at Myriad. “We make these reclassifications very carefully. The science is evolving.”
The company said changing a classification from harmful to uncertain “is a rare event.” Mathes told the Journal she recently learned that just 38 people in Myriad’s database have a gene “of unknown significance.”
Some BRCA-testing labs still consider such genes to be problematic.
Stephen J. Chanock, a geneticist and director of the division of cancer epidemiology and genetics at the National Cancer Institute, described genetic testing as “murky.
“It’s not so simple as, ‘Doctor, do I have to worry or don’t I have to worry?'” he said. “There is a continuum of risk.”
FILED UNDER BREAST CANCER , CANCER , GENETICS , MEDICAL CARE , WOMEN'S HEALTH
SHARE THIS ARTICLE:
Facebook Twitter Flipboard Email Copy
READ NEXT
Trump touts new federal defense spending on Twitter |
